JUVE Patent

Three New Square – UK 2025

JUVE Comment

Three New Square, which continues to challenge market leader 8 New Square and closest competitor 11 South Square in all sectors, is once again showcasing the strength of the talent it has to offer. While in previous years the set’s barristers have been especially present in life sciences cases, the more diverse assortment of recent patent cases has necessitated them to appear for a wider array of clients. But of late Three New Square`s barristers were slightly less visible in SEP cases compared to 8 New Square.

Recommended individuals

Stuart Baran (“highly knowledgeable, with a relaxed yet professional approach”, “a superstar senior junior barrister for any kind of technology, destined to be a great KC”, competitors), Douglas Campbell (“wise, commercial thinking”, competitor), Joe Delaney, Thomas Hinchliffe (“smart guy, easy to work with, good judgment”, competitor), Thomas Lunt (“newcomer, responsive, thoughtful, personable”, competitor), Tom Mitcheson (“wins tough cases in the pharma sector, shows great judgment”, competitor), Katherine Moggridge (“commercial and pragmatic junior, at home on both tech and pharma cases”, competitor), Geoffrey Pritchard (“hard-working and good on hi-tech cases”, competitor), Andrew Waugh

Team

7 KCs, 14 juniors

Clients

Court of Appeal: InterDigital (Douglas Campbell,Joe Delaney) against Lenovo (Thomas Hinchliffe, Jeremy Heald) over telecommunications and FRAND; Optis (Jeremy Heald) against Apple (Thomas Hinchliffe) over telecommunications; Teva and Sandoz (Stuart Baran) against Astellas over overactive bladder treatment; Lufthansa (Tom Mitcheson, Miles Copeland, Alice Hart) against Astronics, Safran and Panasonic over damages in dispute regarding aircraft seats; Comptroller General (Stuart Baran) against Newron Pharmaceuticals regarding the coverage of a marketing authorisation for Parkinson’s drug Xadago. High Court: Xiaomi and Oppo (Thomas Lunt) against Panasonic over SEP portfolio licence; Lenovo (Thomas Lunt) against Ericsson over SEP portfolio licence; InterDigital (Douglas Campbell, Joe Delaney) and for third party NEC (Geoffrey Pritchard) against Lenovo over SEPs; Intel (Thomas Hinchliffe, Miles Copeland) against R2 Semiconductor over chips for computers; Bayer (Andrew Waugh, Alice Hart) against various generics companies over anticoagulant Xarelto; Pfizer (Jeremy Heald) against CureVac over mRNA patents; Moderna (Andrew Waugh, Katherine Moggridge, Stuart Baran, Richard Darby) against Pfizer (Tom Mitcheson, Alice Hart) over mRNA patents; Samsung Bioepis (Tom Mitcheson, Geoffrey Pritchard) against Janssen (Thomas Hinchliffe) over ulcerative colitis drug Stelara; Astellas (Tom Mitcheson, Joe Delaney) against Sandoz and Teva (joint defendants; Katherine Moggridge, Joe Delaney) over treatment for overactive bladder Xtandi; Abbott (Tom Mitcheson, Tim Austen) against Dexcom over glucose-monitoring devices (settled 2025); Novartis and Genentech (Tom Mitcheson, Stuart Baran) against Celltrion over asthma drug Xolair; uniQure (Andrew Waugh, Katherine Moggridge) against Pfizer over haemophilia gene therapy drug; Astronics, Safran, Panasonic (Miles Copeland, Alice Hart) against Lufthansa over liability in case regarding plug sockets for airline seats.

Location

London